Rob Gronkowski Is “Back in The Game” with CBDMEDIC™

Rob Gronkowski returns to professional football with CBDMEDIC playing a key role in his recovery and comeback.

WOONSOCKET, R.I. & TORONTO--(BUSINESS WIRE)-- Abacus Health Products, Inc. (CSE: ABCS, OTCQX: ABAHF) (“Abacus” or the “Company”) today announces its support of Rob Gronkowski’s (Gronk), three-time professional football champion, decision to return to play professional football. Gronkowski partnered with Abacus following nine years of playing in New England. His relationship with Abacus is as a result of his focused effort to recover from the injuries sustained throughout his 9-season career. Following his retirement from professional football in March 2019, Rob Gronkowski announced his partnership with Abacus Health Products, the company behind CBDMEDIC topical pain relief products. In doing so, Gronkowski became an outspoken advocate for CBD in an effort to help athletes and people suffering with pain.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200422005882/en/

Rob Gronkowski returns to professional football. (Source: Abacus)

Gronkowski attributes his use of CBDMEDIC as a key factor in his decision to return to playing football, stating, “I left the game last year after realizing that my body had taken a beating and needed to recover. I’ve taken the recovery process seriously and CBDMEDIC has played a big role in my recovery. Now I’m glad to share that I’m back in the game!” Gronkowski added, “As a result of my personal experience I have advocated for the use of CBD products to be available to both the public and professional athletes and am glad to see changes in policy with sports organizations across the board.”

The use of CBD, an ingredient in hemp extract, in topical medications has experienced a gradual liberalization over the past years as a result of US federal government legislation, the distribution of products by major US retail chains, as well as the allowance by many professional sports leagues.

Abacus’ CBDMEDIC products contain active pharmaceutical ingredients as well as hemp extract. The 2018 Farm Bill, passed in December 2018, permanently removed hemp from the Controlled Substances Act (CSA), and as a result, hemp became an agricultural commodity governed by the U.S. Department of Agriculture (USDA). All hemp used in the manufacture and production of CBDMEDIC products is legally grown and all CBDMEDIC products are 100% THC-free and all-natural. CBDMEDIC products can be purchased over the counter by Americans coast to coast at the leading national retail pharmacy chains.

Abacus and Gronkowski have welcomed the significant changes made across professional sports over the past years that reflect the changing attitudes and awareness in the use of hemp extract and CBD to address a variety of health issues including pain management, which is a positive indicator for the future role of CBD in professional sports.

Abacus and Gronkowski have affirmed that the commercial relationship between the parties continues to be effective following Gronkowski’s decision to return to professional football.

Perry Antelman, CEO of Abacus Health Products stated, ”We look forward to continuing our relationship with Rob and supporting his advocacy efforts in raising awareness of the benefit of our CBDMEDIC topical medications to provide relief for millions of Americans. We are thrilled that Rob is back in the game. It has been an incredible year working closely with Rob - seeing him recover and get into the best shape he's ever been and to know that CBDMEDIC products have been a major part of his journey. Now that Rob has made this phenomenal comeback, he's also scored a huge win for CBD advocacy, a mission that he is dedicated to. To that end, we’re pleased he’s taking time out to help people with crippling arthritis pain in the SURVIVE & THRIVE: COVID-19 Celebrity Challenge Event in support of the Arthritis Foundation at 8pm tonight on their Facebook Live page.”

About SURVIVE & THRIVE

CBDMEDIC™ has teamed up with a cast of celebrities including 3X Pro Football Champion Rob Gronkowski, Hall of Fame Linebacker Brian Urlacher, American Ninja Warrior host Matt Iseman, Sports Illustrated Cover Model Camille Kostek, and the President of Walgreens, Richard Ashworth, for the SURIVIVE & THRIVE: COVID-19 CELEBRITY CHALLENGE in support of the Arthritis Foundation. These celebrities will face entertaining challenges on the Arthritis Foundation’s Facebook Live page at 8pm EST on April 22, 2020 in an effort to raise money for those battling social isolation during COVID-19.

#SurviveandThrive

Link to SURVIVE & THRIVE here: https://bit.ly/34LKsqC

About CBDMEDIC

Launched in 2019, CBDMEDIC offers a line of topical pain medications that combine naturally-derived pain-relieving active OTC drug ingredients with 100% natural emollients (skin softening ingredients), essential oils, and broad-spectrum THC-free, CBD-rich hemp oil to create unique formulations that work with the body for powerful, targeted, and effective pain relief.

Forward-Looking Statements

This news release contains forward-looking statements or information (collectively, "forward-looking statements") within the meaning of applicable securities legislation. Forward-looking statements are based on a number of assumptions and are subject to a number of risks and uncertainties, many of which are beyond the Company's control, that could cause actual results and events to differ materially from those that are disclosed in or implied by such forward-looking statements.

The forward-looking statements contained in this news release include, without limitation, statements relating to the execution of the Company’s growth strategy are based on management's current expectations and are subject to a number of risks, uncertainties and assumptions, including assumptions regarding the Company's ability to efficiently operate its business, market and economic conditions, business prospects or opportunities, future plans and strategies, anticipated events and trends, and regulatory changes that may affect the Company and its customers and industry. There can be no assurance that actual results will not differ materially from those expressed or implied in forward looking statements. Undue reliance should not be placed on forward-looking statements. Additional information about these risks, uncertainties and assumptions is contained under "Risk Factors and Uncertainties" in the Company's annual information form dated April 12, 2019, which is available under the Company's SEDAR profile at www.sedar.com. Each forward-looking statement speaks only as of the date hereof, and the Company undertakes no obligation to correct or update any forward-looking statement, whether as a result of new information, future events or otherwise, except as required by applicable law.

About Abacus Health Products, Inc.

Abacus is a company engaged in the development and commercialization of over-the-counter (OTC) registered topical medications with active pharmaceutical ingredients and which contain organic and natural ingredients, including a cannabinoid-rich hemp extract containing CBD from Cannabis sativa L plant. Abacus’ products are aimed at the rapidly growing markets for topical pain relief and therapeutic skincare and are based on proprietary patent-pending technologies developed by Abacus. Abacus’ formulations combine advanced science with organic and natural ingredients to provide safe relief. Abacus currently offers two lines of products: (i) CBD CLINIC™, marketed to the professional practitioner market, and (ii) CBDMEDIC™, marketed to the consumer market. Abacus’ products are offered across the United States and are produced by a contract manufacturer in an FDA registered and audited manufacturing facility.

To learn more about Abacus, visit www.abacushp.com

View source version on businesswire.com: https://www.businesswire.com/news/home/20200422005882/en/

For further information:

Hank Hague, Chief Financial Officer

Email: investorrelations@abacushp.com

Or

Bill Mitoulas, Investor Relations

Email: bill@abacushp.com

Office: 1.416.479.9547

Source: Abacus Health Products, Inc.